Carac, Efudex, Fluorouracil Newswire

Carac, Efudex, Fluorouracil Newswire

Comprehensive Real-Time News Feed for Carac, Efudex, Fluorouracil (generic).

Results 1 - 20 of 229 in Carac, Efudex, Fluorouracil (generic)

  1. FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case reportRead the original story w/Photo

    Wednesday | BioMed Central

    Adenocarcinomas of the oral cavity are rare neoplasms, and only four cases of primary colonic adenocarcinoma of the tongue have ever been described in literature. Very few information about chemotherapy sensitiveness of this type of neoplasia is available, with only one regimen that showed some activity in a metastatic patient.

    Comment?

  2. This common product may kill your dogRead the original story w/Photo

    Jan 19, 2017 | Bay Area Business Woman

    The Food and Drug Administration is warning pet owners of a common product that could prove deadly if they get a hold of it. Federal authorities are warning pet owners to avoid a product that has killed five dogs that ate some of it.

    Comment?

  3. Chemotherapy for metastatic colon cancer: No effect on survival when...Read the original story w/Photo

    Sunday Apr 22 | BioMed Central

    Since data showing the influence of dose reduction in palliative treatment are rare, the objective of this single center, retrospective study was to further characterize the influence of dose reduction on efficacy of these therapeutic regimens. One hundred nine patients, diagnosed with stage IV colon cancer between 2004 and 2012 and receiving palliative first-line chemotherapy with either FOLFOX or FOLFIRI regimens in our outpatient clinic were analyzed for treatment efficacy.

    Comment?

  4. Treatment of pancreatic ductal adenocarcinoma with tumor antigen...Read the original story w/Photo

    Sunday Apr 22 | BioMed Central

    Pancreatic ductal adenocarcinoma remains the most aggressive cancers with a 5-year survival below 10%. Systemic delivery of chemotherapy drugs has severe side effects in patients with PDA and does not significantly improve overall survival rate.

    Comment?

  5. Retrospective analysis of the impact of anthracycline dose reduction...Read the original story w/Photo

    Thursday Apr 19 | BioMed Central

    The objective of study was to determine the effect of anthracycline dose reduction and chemotherapy delays on 5-year overall survival in patients with stage I-III breast cancer, to establish the impact of molecular subtypes on the anthracycline modification effects and to analyze reasons for such chemotherapy scheme modifications. Medical records of patients with stage I-III breast cancer were reviewed.

    Comment?

  6. Survival after recurrence in patients with gastric cancer who receive ...Read the original story w/Photo

    Thursday Apr 19 | BioMed Central

    Some patients develop recurrence after curative resection and adjuvant chemotherapy. S-1, an oral fluoropyrimidine, is one of the standard regimens in adjuvant chemotherapy, and is also used in first-line treatment for advanced/metastatic gastric cancer.

    Comment?

  7. NuCana plc Announces Appointment of Adam George to its Board of DirectorsRead the original story

    Monday Apr 9 | GlobeNewswire

    NuCana plc , a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying its ProTidea technology to transform some of the most widely prescribed chemotherapy agents into more effective and safer medicines, announced the appointment of Mr. Adam George, UK Managing Director of GW Pharmaceuticals, to its Board as an independent non executive Director. Mr. George will also serve as Chairman of NuCana's Audit Committee.

    Comment?

  8. Radiotherapy-induced anti-tumor immune response and immune-related...Read the original story w/Photo

    Thursday Apr 5 | BioMed Central

    Treatment of recurrent nasopharyngeal carcinoma is a challenging clinical problem. We report the case of a 46 year old male showing excellent response and signs of immunostimulation following re-re-irradiation for recurrent nasopharyngeal carcinoma under systemic treatment with pembrolizumab.

    Comment?

  9. Influence of complete administration of adjuvant chemotherapy cycles...Read the original story w/Photo

    Monday Apr 2 | BioMed Central

    A randomized trial demonstrated that capecitabine is at least as effective as fluorouracil in the adjuvant treatment of patients with locally advanced rectal cancer. However, not all patients receive all planned cycles of chemotherapy.

    Comment?

  10. Chemoradiotherapy versus chemotherapy as adjuvant treatment for...Read the original story w/Photo

    Monday Apr 2 | BioMed Central

    Treatment of localized gastric cancer consists of surgical resection followed by adjuvant treatment. Both chemoradiation and chemotherapy regimens have shown benefit in survival outcomes versus observation.

    Comment?

  11. Colorectal Colon Cancer Therapeutics Market to Flourish with an Impressive CAGR by 2025Read the original story w/Photo

    Tuesday Apr 3 | SBWire

    Colorectal cancer, commonly known as colon cancer, rectal cancer, or bowel cancer, is the development of cancerous cells in the colon or rectum, which are the parts of large intestine. These cells are usually malignant in function and have the ability to spread to other organs of the body.

    Comment?

  12. Duration of adjuvant chemotherapy for advanced colon cancerRead the original story

    Tuesday Apr 3 | GastroHep.com

    This week's issue of the New England Journal of Medicine examines the duration of adjuvant chemotherapy for stage III colon cancer. Since 2004, a regimen of 6 months of treatment with oxaliplatin plus a fluoropyrimidine has been standard adjuvant therapy in patients with stage III colon cancer.

    Comment?

  13. March 2018 Briefing - Cosmetic SurgeryRead the original story w/Photo

    Sunday Apr 1 | Drugs.com

    A previously unrecognized interstitium has been identified in human tissues, according to a study published online March 27 in Scientific Reports . MONDAY, March 26, 2018 -- The gracilis flap can be designed as a functional double paddle flap for a multivector facial reanimation after facial paralysis, according to a study published online March 22 in JAMA Facial Plastic Surgery .

    Comment?

  14. Irinotecan-containing doublet treatment versus irinotecan monotherapy ...Read the original story w/Photo

    Sunday Apr 1 | BioMed Central

    For patients with advanced gastric cancer , second-line chemotherapy regimen remains controversial. The efficacy and safety of irinotecan-containing doublet treatment and irinotecan monotherapy were compared in this systematic analysis.

    Comment?

  15. 3, 6 Month Adjuvant CAPOX Equally Effective for Colon CancerRead the original story w/Photo

    Friday Mar 30 | Drugs.com

    For patients with stage III colon cancer, three months of capecitabine and oxaliplatin therapy is not noninferior to six months of therapy overall, according to a study published in the March 20 issue the New England Journal of Medicine . Axel Grothey, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues performed a prospective pooled analysis of six randomized, phase 3 trials conducted to assess the noninferiority of adjuvant therapy with fluorouracil, leucovorin, and oxaliplatin or CAPOX administered for three versus six months.

    Comment?

  16. MediciNova teams up with Australian cancer center to evaluate MN-166...Read the original story w/Photo

    Thursday Mar 29 | Seeking Alpha

    MediciNova and the University of Sydney Concord Cancer Centre, Australia have agreed to collaborate on a pilot study evaluating MN-166 in chemotherapy-induced peripheral neuropathy in patients metastatic gastrointestinal cancer receiving the chemo agent oxaliplatin. The objective of the 20-subject clinical trial is to determine whether ibudilast can prevent the development of acute neurotoxicity in patients receiving oxaliplatin for the treatment of metastatic gastrointestinal cancer, the effect of ibudilast co-administration on oxaliplatin and fluorouracil and whether it can decrease the severity of chemotherapy-induced peripheral neuropathy.

    Comment?

  17. MediciNova Announces Collaboration with the University of Sydney...Read the original story

    Wednesday Mar 28 | Customer Interaction Solutions

    MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today announced that it plans to initiate a pilot study to evaluate MN-166 in chemotherapy-induced peripheral neuropathy. The clinical trial is a collaborative effort between MediciNova, Inc. and Dr. Janette Vardy, Professor of Cancer Medicine, University of Sydney Concord Cancer Centre in Australia.

    Comment?

  18. What to know about filiform wartsRead the original story w/Photo

    Wednesday Mar 28 | Medical News Today

    Filiform warts are made up of long, thin projections of skin, giving them a distinctive appearance. They often occur around a person's eyes or lips.

    Comment?

  19. Randomized clinical trial testing the efficacy and safety of 0.5%...Read the original story w/Photo

    Mar 26, 2018 | BioMed Central

    The primary clinical manifestation of skin field cancerization is the presence of actinic keratoses . Current treatments for AKs related to skin field cancerization include photodynamic therapy and colchicine.

    Comment?

  20. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy...Read the original story w/Photo

    Mar 26, 2018 | BioMed Central

    Concurrent chemoradiotherapy followed by adjuvant chemotherapy is currently recommended as the standard treatment for locally advanced nasopharyngeal carcinoma . Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy is an alternative strategy for decreasing tumor size and controlling micrometastases before main treatment.

    Comment?